An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B


Kim H. Y., Lampertico P., Nam J. Y., Lee H., Kim S. U., Sinn D. H., ...Daha Fazla

JOURNAL OF HEPATOLOGY, cilt.76, sa.2, ss.311-318, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 76 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.jhep.2021.09.025
  • Dergi Adı: JOURNAL OF HEPATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.311-318
  • Anahtar Kelimeler: liver cancer, deep neural networking, antiviral treatment, chronic hepatitis B, HCC, HBV, ENTECAVIR TREATMENT, SCORING SYSTEM, VALIDATION, LAMIVUDINE, CIRRHOSIS, THERAPY, HISTORY, SCORES
  • Ankara Üniversitesi Adresli: Evet

Özet

Background & Aims: Several models have recently been developed to predict risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to develop and validate an artificial intelligence-assisted prediction model of HCC risk.